WEDBUSH SECURITIES INC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WEDBUSH SECURITIES INC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$30
+36.4%
15,4980.0%0.00%0.0%
Q2 2023$22
-33.3%
15,4980.0%0.00%
-50.0%
Q1 2023$33
+17.9%
15,498
-36.7%
0.00%0.0%
Q4 2022$28
-99.9%
24,498
-2.0%
0.00%0.0%
Q3 2022$41,000
+10.8%
24,998
-10.7%
0.00%0.0%
Q2 2022$37,000
-17.8%
27,9980.0%0.00%0.0%
Q1 2022$45,000
-27.4%
27,998
-6.7%
0.00%
-33.3%
Q4 2021$62,000
-48.3%
29,998
-3.2%
0.00%
-50.0%
Q3 2021$120,000
+106.9%
30,998
+72.2%
0.01%
+100.0%
Q2 2021$58,000
+48.7%
17,9980.0%0.00%
+50.0%
Q1 2021$39,000
-15.2%
17,998
-12.2%
0.00%
-50.0%
Q4 2020$46,000
-2.1%
20,498
+17.1%
0.00%
-20.0%
Q3 2020$47,000
-25.4%
17,498
-14.6%
0.01%
-16.7%
Q2 2020$63,000
+57.5%
20,4980.0%0.01%
+20.0%
Q1 2020$40,000
-34.4%
20,498
-4.7%
0.01%0.0%
Q4 2019$61,000
-22.8%
21,4980.0%0.01%
-37.5%
Q3 2019$79,000
-22.5%
21,498
-12.2%
0.01%
-20.0%
Q2 2019$102,000
+10.9%
24,498
+36.1%
0.01%0.0%
Q1 2019$92,000
+48.4%
17,9980.0%0.01%
+25.0%
Q4 2018$62,000
-42.6%
17,9980.0%0.01%
-33.3%
Q3 2018$108,000
-5.3%
17,9980.0%0.01%
-14.3%
Q2 2018$114,000
-33.3%
17,998
-50.0%
0.01%
-36.4%
Q1 2018$171,000
+67.6%
35,998
+18.0%
0.02%
+83.3%
Q4 2017$102,00030,4990.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders